Cart

Item removed. Undo

Allergic Rhinitis

Allergic Rhinitis

pharmapass.ca

Introduction

ARIA (Allergic Rhinitis and its Impact on Asthma) classification defines allergic rhinitis as seasonal, perennial or intermittent. In addition to increased economic burden, absenteeism and reduced productivity (at work or school), secondary infections, and inappropriate antibiotic use, poor symptom control leads to secondary infections. 

Therapeutic Objective

  • Avoid exposure to allergens to prevent allergic symptoms

  • Control and suppress allergic symptoms

  • Ensure medication side effects don't negatively affect daily life activities

  • Reduce interference with school, work, leisure activities, sleep

Diagnosis

When assessing allergic conditions, a thorough clinical history and physical examination are essential. Here's what to consider:

  • Symptoms: Pay close attention to symptoms like nasal congestion, itching, runny nose, sneezing, postnasal drip, and eye-related issues.

  • Duration and Frequency: Determine whether symptoms are intermittent or persistent and the severity.

  • Triggers: Identify potential allergens such as pollen, animal dander, or other environmental factors.

  • Personal or Family Allergy History: Check for any family history of allergies or atopic conditions (asthma, eczema).

  • Other Medical Conditions: Look for co-existing conditions like sleep apnea, snoring, asthma, or conjunctivitis.

  • Medication History: Some drugs like aspirin (ASA), NSAIDs, or ACE inhibitors may trigger nasal symptoms. Make note of any self-treatment attempts with over-the-counter medications and how effective they were.

  • Nasal Mucosa: Use an otoscope to examine the nasal passages for color and structural issues.

  • Facial Signs: Look for allergic shiners (infraorbital edema), redness, swelling in the eyes, or a transverse nasal crease.

  • Throat: Cobblestone appearance of the posterior oropharynx and visible postnasal drip.

  • Skin Testing: This is the preferred method to confirm allergic sensitivity and identify specific allergens. It helps guide avoidance measures and confirm the diagnosis. If the patient cannot stop antihistamines or has widespread skin issues, consider serum testing instead.

  • Important Note: Patients should stop antihistamines (and some antidepressants) at least 3 days before skin testing, unless otherwise discussed.

  • Serum IgE Testing (ELISA): While more expensive and less sensitive than skin tests, in vitro IgE testing may be used when skin testing isn't feasible. Measuring total IgE isn't generally useful, as it doesn't correlate well with allergies.



Nonpharmacologic Choices

  • Allergen Avoidance: The most effective strategy for managing allergic rhinitis is avoiding allergens that trigger symptoms:

    • Pollen: Use air conditioning to minimize exposure by keeping windows closed. Nasal filters can reduce the amount of pollen and allergens entering the nasal passages.

    • Animal Dander: Removing pets from the home can help alleviate perennial symptoms.

    • Dust Mites: Use impermeable covers for mattresses and pillows. Although evidence is mixed, some studies show a reduction in emergency room visits for asthma after using these covers.

Pharmacologic Choices

  • Intranasal Saline Sprays: Helpful for washing out allergens and mucus from the nasal passages.

  • Antihistamines: Used to alleviate symptoms such as sneezing, rhinorrhea, and nasal itching. Examples include bilastine, cetirizine, desloratadine, and fexofenadine.

    • Most effective when used prophylactically.

    • Second-generation antihistamines are preferred as they cause fewer sedative effects compared to first-generation antihistamines.

  • Decongestants: Help with nasal congestion, but should be used cautiously. Oral pseudoephedrine is generally more effective than phenylephrine.

  • Leukotriene Receptor Antagonists: Montelukast is an option, particularly for patients with coexisting asthma or nasal polyps.

Intranasal Therapy

  • Intranasal Corticosteroids (INCS): These are the mainstay of therapy for moderate to severe symptoms. Regular use offers significant relief from nasal congestion and other symptoms.

  • Combination Therapy: INCS combined with antihistamines (e.g., azelastine/fluticasone) may be useful for patients who do not achieve adequate relief from INCS alone.

Algorithm for Managing Allergic Rhinitis:

Step

Action

Allergen and irritant avoidance

Encourage patients to avoid known allergens or irritants when possible.

Mild or infrequent symptoms

Use intranasal saline spray or a second-generation antihistamine with a decongestant as needed.

Moderate to severe symptoms

Regular use of intranasal corticosteroids, consider adding second-generation antihistamines or decongestants for breakthrough symptoms.

If effective and tolerated

Maintain treatment while the allergen is present.

If not effective

Consider adding leukotriene receptor antagonists or immunotherapy in severe cases.

Severe symptoms

Consider short-term prednisone (5–7 days) with intranasal corticosteroids for rapid relief.

Prolonged symptoms

Immunotherapy may be considered for long-term symptom control.

Drug Table for Management of Allergic Rhinitis

Drug Class

Examples

Common Side Effects

Comments

Antihistamines, less-sedating

Bilastine, Cetirizine, Desloratadine, Fexofenadine

Headache, Drowsiness (high doses)

Effective for acute and chronic allergic rhinitis symptoms. Avoid in patients with liver impairment.

Decongestants

Pseudoephedrine, Phenylephrine

Insomnia, Palpitations, Urinary Retention

Use with caution in patients with hypertension or heart disease. Avoid prolonged use (over 5 days).

Intranasal Corticosteroids

Fluticasone, Mometasone, Budesonide, Ciclesonide

Nosebleeds, Nasal dryness

Considered the first-line therapy for moderate to severe allergic rhinitis.

Leukotriene Receptor Antagonists

Montelukast

Headache, Abdominal pain, Flu-like symptoms

Effective in patients with concurrent asthma or nasal polyps.

Combination Therapy

Azelastine/Fluticasone

Nosebleeds, Dysgeusia (taste disturbance)

Use in patients with persistent symptoms despite using monotherapy.



Comments

There are no comments yet.
Authentication required

You must log in to post a comment.

Log in

Follow us

On social Media